LexisNexis MarketView vs. Signal
A side-by-side comparison based on G2 review data.
| Metric | LexisNexis MarketView | Signal |
|---|---|---|
| Overall rating | 4.1 | 4.2 |
| Review count | 12 | 16 |
| Ease of use | 8.7 | 8.7 |
| Ease of setup | 9.3 | 8.3 |
| Quality of support | 9.4 | 8.9 |
| Meets requirements | 9.0 | 9.1 |
| NPS | 41.666667 | 56.25 |
| Small Business | 41.7% | 31.3% |
| Mid-Market | 41.7% | 37.5% |
| Enterprise | 16.7% | 31.3% |
| Total page views | 62 | 56 |
| Total LLM citations | 21 | 57 |
LexisNexis MarketView
LexisNexis MarketView delivers medical claims-based intelligence to healthcare organizations across the United States.
Signal
Signal's technology empowers brands to create better experiences for their customers and greater business value for their enterprise, starting with the first-party data they already own. We help brands understand the consumer journey and deliver more empathetic, relevant and meaningful messages and experiences.